We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current SDGR market cap is 1.82B. The company's latest EPS is USD 0.5589 and P/E is 44.87.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 35.19M | 42.57M | 74.13M | 36.6M | 47.33M |
Operating Income | -61.13M | -56.19M | -29.73M | -67.43M | -52.73M |
Net Income | 4.28M | -62.02M | -30.67M | -54.72M | -54.05M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 85.54M | 108.1M | 137.93M | 180.96M | 216.67M |
Operating Income | -37.77M | -56.81M | -113.22M | -134.99M | -30.24M |
Net Income | -24.57M | -24.46M | -100.39M | -149.19M | 40.72M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 841.57M | 794.15M | 802.96M | 737.76M | 688.37M |
Total Liabilities | 230.34M | 230.57M | 254.4M | 224.06M | 214.39M |
Total Equity | 611.23M | 563.58M | 548.56M | 513.71M | 473.98M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 155.27M | 746.26M | 756.49M | 688.59M | 802.96M |
Total Liabilities | 57.01M | 122.24M | 199.4M | 240.68M | 254.4M |
Total Equity | -93.32M | 624.02M | 557.09M | 447.91M | 548.56M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -49.54M | -99.48M | -136.73M | -39.28M | -93M |
Investing | 239.45M | 252.65M | 193.03M | 5.08M | 34.66M |
Financing | 5.39M | 6.72M | 9.05M | 8.01M | 9.61M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -26.06M | 16.76M | -70.67M | -119.68M | -136.73M |
Investing | -53.86M | -381.72M | -16.81M | 90.02M | 193.03M |
Financing | 28.68M | 541.27M | 7.95M | 2.11M | 9.05M |
Market Cap | 1.82B |
Price to Earnings Ratio | 44.87 |
Price to Sales Ratio | 8.43 |
Price to Cash Ratio | 11.77 |
Price to Book Ratio | 3.33 |
Dividend Yield | - |
Shares Outstanding | 72.86M |
Average Volume (1 week) | 1.08M |
Average Volume (1 Month) | 892.83k |
52 Week Change | -8.76% |
52 Week High | 33.63 |
52 Week Low | 16.67 |
Spread (Intraday) | 1.21 (4.62%) |
Company Name | Schrodinger Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.schrodinger.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions